Stock SAN SANOFI
Add to a list

ETFs Sanofi

Equities

SAN

FR0000120578

Pharmaceuticals

Real-time Euronext Paris
Other stock markets
 15:13:11 13/03/2026 GMT 		5-day change 1st Jan Change
76.43 EUR -0.12% Intraday chart for Sanofi +0.05% -7.60%
03-10 Brazil drugmaker EMS eyes overseas deals after buying Sanofi unit RE
03-09 Global drugmakers rush to boost US presence as tariff threat looms RE

ETFs positioned on Sanofi

Name Varia. Jan 1. Weight AuM
BBVA ACCION DJ EUROSTOXX 50 ETF - EUR ETF BBVA Accion DJ EUROSTOXX 50 ETF - EUR
-0.72%3.66% 158 M€
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY ETF Nomura NEXT FUNDS International Equity MSCI-KOKUSAI (Yen-Hedged) ETF - JPY
-3.15%3.3% 26 M€
FRANKLIN INTERNATIONAL LOW VOLATILITY HIGH DIVIDEND INDEX ETF - USD ETF Franklin International Low Volatility High Dividend Index ETF - USD
+8.31%2.6% 3,215 M€
FIRST TRUST INTERNATIONAL CAPITAL STRENGTH ETF - CAD ETF First Trust International Capital Strength ETF - CAD
+3.65%2.51% 8 M€
INDEXIQ FACTORS SUSTAINABLE EUROPE EQUITY UCITS ETF - EUR ETF IndexIQ Factors Sustainable Europe Equity UCITS ETF - EUR
-0.10%1.16% 150 M€
DAY HAGAN/NED DAVIS RESEARCH SMART SECTOR INTERNATIONAL ETF - USD ETF Day Hagan/Ned Davis Research Smart Sector International ETF - USD
+0.97%0.82% 32 M€
HARTFORD MULTIFACTOR DEVELOPED MARKETS (EX-US) ETF - USD ETF Hartford Multifactor Developed Markets (ex-US) ETF - USD
+5.58%0.8% 1,111 M€
VANGUARD INTERNATIONAL EQUITY INDEX FUNDS - VANGUARD FTSE ALL-WORLD EX-US ETF ETF Vanguard International Equity Index Funds - Vanguard FTSE All-World ex-US ETF
-2.46%0.46% 33,076 M€
VANECK WORLD EQUAL WEIGHT SCREENED UCITS ETF - EUR ETF VanEck World Equal Weight Screened UCITS ETF - EUR
+1.11%0.41% 1,212 M€
12

Company Profile

Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases; - human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2025, the group had 37 production sites worldwide. Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).
Employees
74,846
Sector
Pharmaceuticals
Calendar
04-23 - Earnings release - Q1 2026
More about the company

Income Statement and Estimates

More financial data

Ratings

Trader

Trader

This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.

Investor

Investor

This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.

Global

Global

This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quality

Quality

This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

ESG MSCI

ESG MSCI

The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

A
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
76.52EUR
Average target price
98.49EUR
Spread / Average Target
+28.71%
Consensus
EPS Estimates
Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SAN Stock
  4. ETFs Sanofi
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

MarketScreener -
United-States
MarketScreener Canada -
Canada

MIDDLE EAST

MarketScreener Saudi Arabia -
Saudi Arabia
MarketScreener UAE Emirates -
United Arab Emirates

EUROPE

Zonebourse -
France
MarketScreener Deutschland -
Deutschland
Zonebourse Suisse -
Suisse
MarketScreener Schweiz -
Schweiz
MarketScreener Italia -
Italia
MarketScreener Österreich -
Österreich
MarketScreener België -
België
MarketScreener Nederland -
Nederland
MarketScreener España -
España
MarketScreener Sverige -
Sverige
MarketScreener UK -
United Kingdom

APAC

MarketScreener Australia -
Australia
MarketScreener India -
India
MarketScreener Hong Kong -
Hong Kong
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition